Phase 3 trials needed to determine efficacy of UBI's vaccine: experts

Experts in Taiwan said Monday that the results of the clinical trials conducted so far by United Biomedical Inc. (UBI) for its COVID-19 vaccine candidate have shown inconclusive results regarding its efficacy and that it requires further trials.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)